Both Retatrutide and Survodutide, like all incretin-based obesity medications, require consideration of long-term treatment strategies
The monitoring protocol remains the same, but the interpretation of results and dose adjustment decisions require specialized expertise
This advanced formulation is particularly beneficial for individuals at increased risk of deficiency, including the elderly, vegetarians, vegans, and those with GI conditions that hinder B12 absorption, such as pernicious anemia, celiac disease, Crohns disease, and irritable bowel syndrome (IBS), among others
Lower strengths (2.5 mg/ml) are ideal for beginners, while experienced users or those not responding well may benefit from a higher dose 5 mg/ml
The Drug Shortage Exception (How Compounding GLP-1 Became Legal) Compounding pharmacies don't have blanket authority to reproduce any commercial medication